N2:DRUDEV
UK scientists look to repurpose existing antiviral drugs for COVID
(Reuters) -British researchers want to repurpose existing antiviral therapies to treat COVID-19, the University of Oxford said on Friday, in...
Read more
Ivermectin shows ‘antiviral effect’ against COVID, Japanese company says
TOKYO (Reuters) - Japanese trading and pharmaceuticals company Kowa Co Ltd on Monday said that anti-parasite drug ivermectin showed an...
Read more
AstraZeneca says early trial data indicates third dose helps against Omicron
By Pushkala Aripaka and Ludwig Burger (Reuters) -AstraZeneca said on Thursday that preliminary data from a trial showed that its...
Read more
AstraZeneca vaccine booster works against Omicron, Oxford lab study finds
By Pushkala Aripaka (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant,...
Read more
France cancels order for Merck’s COVID-19 antiviral drug
By Reuters Staff PARIS (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing...
Read more
Exclusive: Vaccine maker Serum waives AstraZeneca shot indemnity for refugee programme
By Francesco Guarascio and Pushkala Aripaka (Reuters) - The Serum Institute of India (SII) has waived its protection from legal...
Read more
Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children
By Clara-Laeila Laudette and Conor Humphries MADRID/DUBLIN (Reuters) -Pfizer Inc said on Friday the COVID-19 pandemic could extend through next...
Read more
EU drug regulator won’t rule on Merck COVID-19 pill before Christmas – source
By Emilio Parodi MILAN (Reuters) - The EU drug regulator will not decide whether to approve Merck & Co's COVID-19...
Read more
Vaccine mandates ‘absolute last resort’, WHO Europe head says
COPENHAGEN (Reuters) -Mandatory vaccinations against the coronavirus are an "absolute last resort", the World Health Organization's top Europe official said...
Read more
EU could approve shot against new coronavirus variant in 3-4 months
By Ludwig Burger and Pushkala Aripaka (Reuters) -The EU drug regulator said on Tuesday it could approve vaccines adapted to...
Read more
Global licence deal to provide COVID antibody test tech free to poorer countries – WHO
GENEVA (Reuters) - A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and...
Read more
Holmes defends beliefs in Theranos technology at her fraud trial
By Jody Godoy SAN JOSE, Calif. (Reuters) -Theranos founder Elizabeth Holmes defended her leadership at the now-defunct blood-testing startup on...
Read more
Exclusive-Amid spike in cases, EU to shortly approve first COVID antibody drugs – sources
By Francesco Guarascio BRUSSELS (Reuters) - The European Union drugs regulator is set to authorise the use of two monoclonal...
Read more
Britain approves Merck’s COVID-19 pill in world first
By Pushkala Aripaka (Reuters) -Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19...
Read more
Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says
By Carl O'Donnell and Dania Nadeem (Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a...
Read more
Exclusive-EU decision on Russia’s Sputnik V shot ‘impossible’ this year – source
By Emilio Parodi and Polina Nikolskaya (Reuters) -The EU drug regulator is unlikely to decide whether to approve Russia’s Sputnik...
Read more
EU fails to confirm if women, young adults at higher clot risk from AstraZeneca shot
(Reuters) - Europe's drugs regulator said on Friday it could not confirm if women and young adults were at a...
Read more